Misdiagnoses, vaccine safety reporting and drugmakers’ “corporate capture” earned substantial ink in a hotly anticipated report from the White House’s Make America Healthy Again Commission, chaired by Department of Health and Human Services Secretary Robert F. Kennedy Jr. More: MAHA
read moreSanofi has officially opened its swanky new offices in Morristown, New Jersey, where nearly 2,000 employees recently relocated. The drugmaker invested $130 million in the new facility, which features flexible workspaces, wellness rooms, a public-facing restaurant and “the largest outdoor
read moreItovebi, when added to Pfizer’s Ibrance and AstraZeneca’s Faslodex, cut the risk of death by 33% in a phase 3 trial of certain breast cancer patients. More: ASCO: Roche details Itovebi's survival benefit in certain breast cancers, further backing blockbuster
read moreSamsung Biologics will devote itself fully to contract manufacturing under a plan to spin off a new investment holding company that will oversee the drugmaker’s biosimilar subsidiary Samsung Bioepis. Samsung Bio attributed the decision to industry concerns about conflicts-of-interest between
read moreAstraZeneca and Merck are still leading the pack when it comes to how oncologists perceive makers of cancer drugs, according to a new report from ZoomRx. More: AstraZeneca, Merck duke it out at the top of oncologists’ pharma perception ranking
read morePatients new to branded Wegovy can access a one-month supply for $199 as part of Novo’s efforts to reach more patients in a market that’s been long affected by compounders. More: Novo offers Wegovy discount for new patients, launches new
read more© 1994 - 2026 B.M. Pharmaceuticals